Counterfeit forms of weight loss and diabetes drugs are endangering consumers, and Oklahoma General Attorney Gentner Drummond wants to take action against what he calls "bad actors" in the ...

Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

One such breakthrough comes from PharmaZee, a leading provider of GLP-1 medication, particularly Semaglutide ... the pricing structure, the benefits, and common FAQs. GLP-1, or glucagon-like ...

Vivani Medical, Inc. (NASDAQ:VANI) and Okava Pharmaceuticals, Inc. expanded their collaboration to include dogs in the development of OKV-119, a long-acting GLP-1 therapy for weight management, ...

Shares of Eli Lilly (LLY) jumped on Thursday morning after the company announced topline Phase 3 results from ACHIEVE-1, evaluating the safety ...

An expert has explained that if you take weight-loss drugs you might get 'Ozempic mouth', though it's not all bad.

The structure of this expanded partnership minimizes ... In March, Vivani Medical released preclinical data for NPM-139, its subdermal semaglutide implant under development for chronic weight ...

Seeking Alpha analyst Stephen Ayers shares his views on which weight-loss drug stock looks most attractive for investors ...

A new oral weight loss pill shows results similar to Ozempic and Wegovy injections in the treatment of obesity.

Berberine is a powder made from different plants. It has many benefits, including improving blood sugar levels, reducing ...